Overview
Congenitally corrected transposition of the great arteries (ccTGA), also known as levo-transposition of the great arteries (L-TGA) or ventricular inversion, is a rare congenital heart defect in which the heart's two lower chambers (ventricles) are reversed. Despite the somewhat confusing name containing 'corrected,' the condition is not truly corrected — the aorta arises from the morphologic right ventricle and the pulmonary artery arises from the morphologic left ventricle. Because both the atrioventricular and ventriculoarterial connections are discordant (a 'double discordance'), blood flow follows a physiologically appropriate circuit: deoxygenated blood still reaches the lungs and oxygenated blood still reaches the body. However, the morphologic right ventricle must function as the systemic ventricle, a role for which it is not ideally designed. Many patients with ccTGA also have associated cardiac anomalies, which are present in the majority of cases. These commonly include ventricular septal defects (VSD), pulmonary or subpulmonary stenosis, abnormalities of the systemic (tricuspid) atrioventricular valve including Ebstein-like malformation, and conduction system abnormalities leading to heart block. Patients without associated defects may remain asymptomatic for decades, but progressive systemic right ventricular dysfunction and systemic atrioventricular valve regurgitation often develop over time, leading to heart failure symptoms such as exercise intolerance, fatigue, dyspnea, and arrhythmias. Treatment depends on the presence and severity of associated defects and the function of the systemic right ventricle. Surgical options include conventional repair of associated lesions (VSD closure, relief of pulmonary stenosis) or anatomic repair strategies such as the double switch operation (combining an atrial switch with an arterial switch), which restores the morphologic left ventricle to the systemic circulation. Medical management of heart failure and arrhythmias, pacemaker implantation for complete heart block, and ultimately cardiac transplantation may be necessary in advanced cases. Lifelong cardiology follow-up is essential for all patients with ccTGA.
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
2 eventsXie Mingxing
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Congenitally uncorrected transposition of the great arteries.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenitally uncorrected transposition of the great arteries at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersErasmus Medical Center
📍 Rotterdam
👤 Robert Rissmann, Professor
Leiden University Medical Center
📍 Leiden
👤 Robert Rissmann, Professor
Stanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Congenitally uncorrected transposition of the great arteries.
Community
No community posts yet. Be the first to share your experience with Congenitally uncorrected transposition of the great arteries.
Start the conversation →Latest news about Congenitally uncorrected transposition of the great arteries
Disease timeline:
New recruiting trial: Beta-blocker Administration for Cardiomyocyte Division
A new clinical trial is recruiting patients for Congenitally uncorrected transposition of the great arteries
New trial: Effects Branch PA Stenting d-TGA, ToF and TA
Phase NA trial recruiting. Percutaneous intervention (stent) for PA stenosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenitally uncorrected transposition of the great arteries
What is Congenitally uncorrected transposition of the great arteries?
Congenitally corrected transposition of the great arteries (ccTGA), also known as levo-transposition of the great arteries (L-TGA) or ventricular inversion, is a rare congenital heart defect in which the heart's two lower chambers (ventricles) are reversed. Despite the somewhat confusing name containing 'corrected,' the condition is not truly corrected — the aorta arises from the morphologic right ventricle and the pulmonary artery arises from the morphologic left ventricle. Because both the atrioventricular and ventriculoarterial connections are discordant (a 'double discordance'), blood flow
How is Congenitally uncorrected transposition of the great arteries inherited?
Congenitally uncorrected transposition of the great arteries follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Congenitally uncorrected transposition of the great arteries?
1 specialists and care centers treating Congenitally uncorrected transposition of the great arteries are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.